These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 16429424)
1. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis. Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424 [TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of lung disease in cystic fibrosis. Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR; N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846 [TBL] [Abstract][Full Text] [Related]
3. ENaCbeta and gamma genes as modifier genes in cystic fibrosis. Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176 [TBL] [Abstract][Full Text] [Related]
5. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation. Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593 [TBL] [Abstract][Full Text] [Related]
6. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin. Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455 [TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation for pulmonary function in cystic fibrosis. de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263 [TBL] [Abstract][Full Text] [Related]
8. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis. De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919 [TBL] [Abstract][Full Text] [Related]
9. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035 [TBL] [Abstract][Full Text] [Related]
10. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy. Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032 [TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis mutations with widely variable phenotype: the D1152H example. Mussaffi H; Prais D; Mei-Zahav M; Blau H Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673 [TBL] [Abstract][Full Text] [Related]
13. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations. Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960 [TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France. Duguépéroux I; De Braekeleer M; J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945 [TBL] [Abstract][Full Text] [Related]
15. MBL2 polymorphisms screening in a regional Italian CF Center. Trevisiol C; Boniotto M; Giglio L; Poli F; Morgutti M; Crovella S J Cyst Fibros; 2005 Sep; 4(3):189-91. PubMed ID: 16046196 [TBL] [Abstract][Full Text] [Related]
16. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype. Yarden J; Radojkovic D; De Boeck K; Macek M; Zemkova D; Vavrova V; Vlietinck R; Cassiman JJ; Cuppens H Thorax; 2005 Apr; 60(4):320-5. PubMed ID: 15790988 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of the spectra of mutations and polymorphic loci of cystic fibrosis transmembrane conductance regulator in the population of Bashkortostan]. Korytina GF; Viktorova TV; Baĭkova GV; Khusnutdinova EK Genetika; 2002 Sep; 38(9):1270-5. PubMed ID: 12391889 [TBL] [Abstract][Full Text] [Related]
19. Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis. Lin Z; Thorenoor N; Wu R; DiAngelo SL; Ye M; Thomas NJ; Liao X; Lin TR; Warren S; Floros J Front Immunol; 2018; 9():2256. PubMed ID: 30333828 [TBL] [Abstract][Full Text] [Related]
20. An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study. Tomaiuolo R; Degiorgio D; Coviello DA; Baccarelli A; Elce A; Raia V; Motta V; Seia M; Castaldo G; Colombo C Dig Liver Dis; 2009 Nov; 41(11):817-22. PubMed ID: 19467940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]